Stockscreener 앱 받기
0.2824
0.46%
0.0013
시장 영업 전:
.29
0.0076
+2.69%
IGC Pharma Inc 주식(IGC)의 최신 뉴스
PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First? - openPR.com
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - ACCESS Newswire
IGC Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
IGC Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical-Stage Pipeline Stays in FocusWeak Earnings Momentum - careplusvn.com
IGC Pharma Evaluates Recovery After Left Verdict - ACCESS Newswire
Price to earnings forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Pharma (NYSE: IGC) Target Raised on Alzheimer's 2027 Outlook - marketscreener.com
IGC Pharma (IGC) Slips to $0.31 as Key Support Comes into FocusMerger Arbitrage - dars.gov.et
Nasdaq 30's VIVS, IGC, RIME, AIXI Stocks Now - openPR.com
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now - FinancialContent
IGC Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress Supports SentimentMargin Improvement Report - careplusvn.com
IGC (IGC) Technicals: Falls 0.65% to $0.31 on the Day; Level Watch: $0.29 and $0.33 Define the Nearby Reference Levels in the Latest ReadingLarge Cap Trends - vinanet.vn
MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now - openPR.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com India
IGC (IGC) Earnings Data Review: The Bottom-Line Figure Outpaces Its Comparison at the Close; Session Reaction: Shares Move 1.43% Higher in the Current UpdatePost-Earnings Reaction - vinanet.vn
IGC Pharma earnings matched, revenue fell short of estimates - Investing.com
IGC Pharma Releases Q2 2026 Financial Results - AlphaStreet
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - openPR.com
IGC Pharma execs buy 4.27M shares to settle $1.15M debt - scanx.trade
IGC Pharma Q2 Results: Sales up 39% YoY, EPS loss widens to $(0.03) - scanx.trade
IGC Looks 24.1% Overvalued on GF Value™ - GuruFocus
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure - Finviz
IGC Pharma Q2 Results: CALMA Nears Enrollment Closure - accessnewswire.com
IGC Pharma, Inc. 2026: Revenue $265K, EPS ($0.03) — 10-Q Summary - TradingView
IGC Pharma (NYSE: IGC) widens loss while Phase 2 Alzheimer’s trial hits key milestone - Stock Titan
IGC Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build - openPR.com
IGC Pharma (NYSE American:IGC): What Does the Latest Update Mean for Clinical Development? - Kalkine Media
IGC Pharma Inc (IGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IGC Pharma (NYSE AMERICAN:IGC): What Could Today’s regulatory execution Update Reveal? - Kalkine Media
IGC Pharma (NYSE AMERICAN:IGC): What Could Today’s cannabinoid research progress Update Reveal? - Kalkine Media
Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to WatchPlus More in Focus - openPR.com
Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to Watch – Plus More in Focus - FinancialContent
IGC Looks 21.6% Overvalued on GF Value™ - GuruFocus
IGC Pharma Advances CALMA Toward Q4 Topline Readout - ACCESS Newswire
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout - Corsicana Daily Sun
IGC Pharma Inc (IGS1.DU) balance sheet - Yahoo Finance UK
Enterprise value to revenue forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Pharma Inc (IGC) Stock News Today - TradingKey
Price to sales forward of IGC Pharma, Inc. – MUN:IGS1 - TradingView
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch - openpr.com
IGC Q1 2026 Earnings: Narrower-Than-Expected Loss Marks 14.16% EPS BeatSaaS Earnings Trends - careplusvn.com
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com
IGC Pharma, Inc. Revenue Breakdown – AMEX:IGC - TradingView
IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign - The Batesville Daily Guard
IGC|IGC Pharma Inc|Price:0.266|Chg%:+0.002 - TradingKey
IGC Pharma Hovers Near Support as Slight Decline Tests $0.26 LevelRounding Bottom - dars.gov.et
IGC|IGC Pharma Inc|Price:0.248|Chg%:-0.001 - TradingKey
IGC Pharma Inc (IGC) Cash Flow - TradingKey
IGC Pharma Inc (IGC) Balance Sheet - TradingKey
IGC Pharma Inc (IGC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IGC Pharma Inc (IGC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IGC Pharma Inc (IGC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
3.06%
2.55%
자본화:
|
볼륨(24시간):